The effect of intranasal steroid in the treatment of allergic rhinitis with and without oral antihistamine (comparative study)
DOI:
https://doi.org/10.56056/amj.2022.149Keywords:
Allergic rhinitis, Mometasone furoate, Desloratadine tablet, Total symptomAbstract
Backgrounds & objectives: Numerous studies have investigated the efficacies of steroid nasal sprays for adults with allergic rhinitis. However, research on their effectiveness in combination with oral antihistamines is limited. This study compared the efficacies of a steroid nasal spray (mometasone furoate) with an oral antihistamine (desloratadine tablet) in the treatment of allergic rhinitis.
Methods: A randomized clinical trial was conducted on 120 patients diagnosed with allergic rhinitis. The patients who attended the outpatient department at Rizgary Teaching Hospital in Erbil city were examined for clinical features of allergic rhinitis. Patients with moderate-severe and/or persistent symptoms were included in this study. In this study, 120 patients with allergic rhinitis were randomly assigned to receive mometasone furoate nasal spray alone (control group) and a combination of mometasone nasal spray and oral desloratadine (experimental group).
Results: This study showed a statistically significant effect of combination therapy in comparison with intranasal steroids alone. The effect of the combination therapy was more apparent among patients with moderate-severe persistent symptoms. The score was 11.05 in patients who received the combination therapy compared with 7.85 among patients who received single therapy. Conclusions: This study showed that the efficacy of mometasone nasal spray in combination with antihistamine was higher than single steroid nasal sprays therapy.
Downloads
References
-Salo PM, Calatroni A, Gergen PJ, et al. Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2011;127(5):1226-35. e7.
-Anolik R, Group MFNSWLS. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100(3):264-71.
-Yang Y, Wang Y, Lv L, et al. The prevalence and associated lifestyle risk factors of self-reported allergic rhinitis in Kazakh population of Fukang City. Medicine. 2017; 96 (39), e8032.
-Iriz A, Karabulut H, Dagli M, et al. The effect of the use of azelastine hcl and triamcinolone acetonide on symptoms in patients with seasonal allergic rhinitis. GMJ. 2009;20(4):173-5.
-Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1): S45-S53.
-Gevorgyan A, Segboer C, Chusakul S, et al. Intranasal corticosteroids for non-allergic rhinitis. Cochrane Database of Systematic Reviews. 2013;6. Available from: https://www.cochrane.org/CD010592/ENT_intranasal-corticosteroids-non-allergic-rhinitis
-Okubo K, Kurono Y, Ichimura K, et al. Japanese guidelines for allergic rhinitis 2017. Aller Int. 2017;66(2):205-19.
-Bro?ek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Ann Allergy Asthma Immunol 2010;126(3):466-76.
-Sukumaran T. Allergic rhinitis and co-morbidities training module (ARCTM). Indian pediatrics. 2011;48(7):511-3.
-Staevska MT, Baraniuk JN. Differential diagnosis of persistent nonallergic rhinitis and rhinosinusitis syndromes. Nonallergic Rhinitis: CRC Press; 2016: 57-76.
-Patel P, Salapatek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol 2019;122(2):160-6. e1.
-Sheth K. Evaluating the safety of intranasal steroids in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2008;4(3):125-9.
-Ratner PH, Hampel F, Van Bavel J, et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100(1):74-81.
-Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010;105(2):168-73.
-Meltzer EO, LaForce C, Ratner P, et al., editors. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy and asthma proc; 2012: OceanSide Publications, Inc.
-Andrews CP, Mohar D, Agarwal P, Salhi Y, Tantry SK, editors. Efficacy and safety of once-daily and twice-daily olopatadine/mometasone nasal spray treatment in seasonal allergic rhinitis. Poster presented at the 75th annual meeting of the American College of Allergy, Asthma, and Immunology; 2017.
-Ratner P, Hampel F, Breazna A, Caracta C, Tantry S, editors. Efficacy and safety of olopatadine/mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Poster presented at the 75th annual meeting of the American College of Allergy, Asthma, and Immunology; 2017.
-Can D, Tanaç R, Demir E, Gülen F, Veral A, editors. Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient? Allergy Asthma Proc 2006. 27(3):248-53.
-Nielsen LP, Mygind N, Dahl R. Intranasal corticosteroids for allergic rhinitis. Drugs. 2001;61(11):1563-79.
-Marple BF, Fornadley JA, Patel AA, et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007;136(6): S107-S124.
-Renwick A. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes. Clin Exp Allergy 1999; 29:116-24.
-Simons FER, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. NEJM. 1994;330(23):1663-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Moyeser Abdulrahman Yaseen, Salar Majeed Piro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
